Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use
Joeri W. van Straalen(University Medical Center Utrecht), Joost F. Swart(Trinity College Dublin), Marite Rygg(Norwegian University of Science and Technology), Marija Jelušić(Unknown), Violeta Panavienė(Vilnius University), Flávio Sztajnbok(Universidade Federal do Rio de Janeiro), Despoina Maritsi(National and Kapodistrian University of Athens), Pavla Doležalová(Charles University), Sheila Knupp Feitosa de Oliveira(Universidade Federal do Rio de Janeiro), Nico Wulffraat(Utrecht University), Roline M. Krol(Wilhelmina Children's Hospital), Marco Cattalini(University of Brescia), Ellen Nordal(University Hospital of North Norway), Claudia Saad‐Magalhães(Universidade Estadual Paulista (Unesp)), Gordana Sušić, Sujata Sawhney(Sir Ganga Ram Hospital), Nicolino Ruperto(Istituto Giannina Gaslini), Nadina Rubio‐Pérez(Universidad Autónoma de Nuevo León), Tamás Constantin(Semmelweis University), Laura Marinela Ailioaie(Alexandru Ioan Cuza University), Sytze de Roock(Wilhelmina Children's Hospital), Gabriella Giancane(Istituto Giannina Gaslini)
Cited by 26
Related Papers
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
EULAR recommendations for the management of familial Mediterranean fever
|Annals of the Rheumatic Diseases|2016|593
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
|Arthritis & Rheumatism|1998|217